Sorell L. Schwartz

1.0k total citations
48 papers, 701 citations indexed

About

Sorell L. Schwartz is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Sorell L. Schwartz has authored 48 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Physiology and 6 papers in Cell Biology. Recurrent topics in Sorell L. Schwartz's work include Amino Acid Enzymes and Metabolism (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Biomedical Research and Pathophysiology (4 papers). Sorell L. Schwartz is often cited by papers focused on Amino Acid Enzymes and Metabolism (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Biomedical Research and Pathophysiology (4 papers). Sorell L. Schwartz collaborates with scholars based in United States, Greece and Australia. Sorell L. Schwartz's co-authors include Herbert McKennis, Paul D. Doolan, Edward R. Bowman, Jude R. Hayes, Lennox B. Turnbull, Einosuke Tamaki, Joseph F. Borzelleca, Denise E. Robinson, Raphael J. Witorsch and Henry Yeager and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

Sorell L. Schwartz

48 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sorell L. Schwartz United States 15 187 100 99 74 70 48 701
Maryse Baradat France 10 339 1.8× 124 1.2× 128 1.3× 90 1.2× 55 0.8× 18 878
Takeshi Tani Japan 15 195 1.0× 78 0.8× 26 0.3× 54 0.7× 63 0.9× 46 764
Jeffrey W. Cox United States 13 158 0.8× 66 0.7× 65 0.7× 28 0.4× 31 0.4× 24 592
Georg Karlaganis Switzerland 20 189 1.0× 63 0.6× 82 0.8× 50 0.7× 27 0.4× 56 1.1k
Susan M. Deneke United States 11 410 2.2× 157 1.6× 73 0.7× 169 2.3× 104 1.5× 15 1.3k
J A Knight United States 9 283 1.5× 208 2.1× 67 0.7× 240 3.2× 76 1.1× 14 1.1k
Asoke G. Datta India 15 296 1.6× 197 2.0× 38 0.4× 71 1.0× 33 0.5× 56 846
Leonid Grinberg Israel 15 343 1.8× 179 1.8× 37 0.4× 101 1.4× 69 1.0× 21 1.0k
K Nishiki United States 15 382 2.0× 214 2.1× 28 0.3× 96 1.3× 29 0.4× 19 954
Nigel Roome France 10 179 1.0× 60 0.6× 83 0.8× 64 0.9× 27 0.4× 20 848

Countries citing papers authored by Sorell L. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Sorell L. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sorell L. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sorell L. Schwartz more than expected).

Fields of papers citing papers by Sorell L. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sorell L. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sorell L. Schwartz. The network helps show where Sorell L. Schwartz may publish in the future.

Co-authorship network of co-authors of Sorell L. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Sorell L. Schwartz. A scholar is included among the top collaborators of Sorell L. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sorell L. Schwartz. Sorell L. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bies, Robert R., et al.. (2022). A Physiologically-Based Pharmacokinetic Model of the Brain Considering Regional Lipid Variance. Journal of Pharmacology and Experimental Therapeutics. 383(3). 217–226. 2 indexed citations
2.
Schwartz, Sorell L., et al.. (2019). Estimating parameters of nonlinear dynamic systems in pharmacology using chaos synchronization and grid search. Journal of Pharmacokinetics and Pharmacodynamics. 46(2). 193–210. 15 indexed citations
3.
Craig, Morgan, et al.. (2018). Chaos synchronization and Nelder-Mead search for parameter estimation in nonlinear pharmacological systems: Estimating tumor antigenicity in a model of immunotherapy. Progress in Biophysics and Molecular Biology. 139. 23–30. 4 indexed citations
4.
Mitkus, Robert J., Maureen A. Hess, & Sorell L. Schwartz. (2013). Pharmacokinetic modeling as an approach to assessing the safety of residual formaldehyde in infant vaccines. Vaccine. 31(25). 2738–2743. 23 indexed citations
5.
Schwartz, Sorell L., et al.. (2002). Kinetic and Dynamic Models of Diving Gases in Decompression Sickness Prevention. Clinical Pharmacokinetics. 41(6). 389–402. 6 indexed citations
6.
Ford, Earl S., et al.. (1995). Deaths from Acute Exposure to Trichloroethylene. Journal of Occupational and Environmental Medicine. 37(6). 749–754. 10 indexed citations
7.
Schwartz, Sorell L., et al.. (1994). CMATRIX: Software for physiologically based pharmacokinetic modeling using a symbolic matrix representation system. Computers in Biology and Medicine. 24(4). 269–276. 7 indexed citations
8.
Ruı́z-Cabello, Jesús, et al.. (1994). Measurement of Pharmacodynamic Effects of Dexamethasone on Epidermis by Phosphorus Nuclear Magnetic Resonance Spectroscopy in Vitro. Journal of Pharmaceutical Sciences. 83(9). 1339–1344. 7 indexed citations
9.
Dretchen, Kenneth L., Sorell L. Schwartz, Thomas J. Boll, et al.. (1992). Cognitive Dysfunction in a Patient with Long-Term Occupational Exposure to Ethylene Oxide. Journal of Occupational and Environmental Medicine. 34(11). 1106–1113. 4 indexed citations
10.
Robinson, Denise E., et al.. (1992). A physiologically based pharmacokinetic model for nicotine and cotinine in man. Journal of Pharmacokinetics and Biopharmaceutics. 20(6). 591–609. 42 indexed citations
11.
Schwartz, Sorell L.. (1992). Freon and Hypertension-Reply. JAMA. 268(12). 1541–1541. 1 indexed citations
12.
Jennings, Anthony S., et al.. (1990). Effects of oral erythrosine (2′,4′,5′,7′-tetraiodofluorescein) on the pituitary-thyroid axis in rats. Toxicology and Applied Pharmacology. 103(3). 549–556. 40 indexed citations
13.
Siddoway, Lyle A., Sorell L. Schwartz, Jean T. Barbey, & Raymond L. Woosley. (1990). Clinical pharmacokinetics of moricizine. The American Journal of Cardiology. 65(8). 21–25. 8 indexed citations
14.
Dubois, Michel, et al.. (1989). Alfentanil Infusion in Neurosurgical Patients. Journal of Neurosurgical Anesthesiology. 1(4). 328–332. 5 indexed citations
15.
GARDNER, DAVID F., Robert D. Utiger, Sorell L. Schwartz, et al.. (1987). Effects of oral erythrosine (2′,4′,5′,7′-tetraiodofluorescein) on thyroid function in normal men. Toxicology and Applied Pharmacology. 91(3). 299–304. 28 indexed citations
16.
Schwartz, Sorell L., et al.. (1977). Accumulation of norepinephrine by macrophages and relationships to known uptake processes.. Journal of Pharmacology and Experimental Therapeutics. 201(3). 636–643. 19 indexed citations
17.
Schwartz, Sorell L., et al.. (1972). INHIBITION OF PINOCYTOSIS BY NICOTINE. Journal of Pharmacology and Experimental Therapeutics. 183(2). 370–377. 12 indexed citations
18.
Schwartz, Sorell L., et al.. (1971). Induction of vacuolation in the mouse peritoneal macrophage by EDTA. Experimental Cell Research. 66(1). 253–257. 1 indexed citations
19.
Virgilio, Richard W., et al.. (1970). Comparison of inulin and chromium-edta spaces in the nephrectomized baboon. Journal of Surgical Research. 10(8). 370–376. 6 indexed citations
20.
Schwartz, Sorell L. & Herbert McKennis. (1963). Studies on the Degradation of the Pyrrolidine Ring of (—)-Nicotine in Vivo. Journal of Biological Chemistry. 238(5). 1807–1812. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026